Background Problems with the use of inhalers by patients were noted shortly after the
launch of the metered-dose inhaler (MDI) and persist today. We aimed to assess the most …

Dry powder inhalers (DPIs) are widely and increasingly used in clinical practice because
they represent a substantial advancement in inhalation technology. The effectiveness of a …

Dry powder bronchodilator devices have an internal resistance. Effective use depends on
the patient generating an adequate inspiratory flow to break up the powder packets into …

Pulmonary drug delivery is currently the focus of accelerated research and development
because of the potential to produce maximum therapeutic benefit to patients by directly …

Successful treatment for respiratory diseases relies on effective delivery of medication to the
lungs using an inhalation device. Different inhalers have distinct characteristics affecting …

Background Inhaled drugs are the mainstay of treatment for lung diseases such as asthma
and chronic obstructive pulmonary disease. However, failure to use inhalation devices …

Errors in the use of different inhalers were investigated in patients naive to the devices under
investigation in a multicentre, single-visit, randomised, open-label, cross-over study. Patients …

La enfermedad pulmonar obstructiva crónica (EPOC) se caracteriza esencialmente por una
limitación crónica al flujo aéreo poco reversible y asociada principalmente al humo de …

Dry powder inhalers (DPIs) are an important and increasingly investigated method of
modern therapy for a growing number of respiratory diseases. DPIs are a promising option …

Chronic obstructive pulmonary disease (COPD) is a major cause of death and disability
worldwide. Inhaled bronchodilators are the mainstay of COPD pharmacological treatment …